Interventions affecting the nitric oxide pathway versus placebo or no therapy for fetal growth restriction in pregnancy

Author:

Pels Anouk1,Ganzevoort Wessel1,Kenny Louise C2,Baker Philip N3,von Dadelszen Peter4,Gluud Christian5,Kariya Chirag T6,Leemhuis Aleid G7,Groom Katie M8,Sharp Andrew N9,Magee Laura A4,Jakobsen Janus C10,Mol Ben Willem J1112,Papageorghiou Aris T13

Affiliation:

1. Department of Obstetrics and Gynecology; Amsterdam UMC, University of Amsterdam; Amsterdam Netherlands

2. Faculty of Health and Life Sciences; University of Liverpool; Liverpool UK

3. College of Life Sciences; University of Leicester; Leicester UK

4. Department of Obstetrics and Gynaecology; King's College London; London UK

5. Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research; Capital Region, Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark

6. Department of Obstetrics and Gynaecology; University of British Columbia; Vancouver Canada

7. Amsterdam UMC, University of Amsterdam, Emma Children’s Hospital; Amsterdam Netherlands

8. Department of Obstetrics and Gynaecology; University of Auckland; Auckland New Zealand

9. Department of Women's and Children's Health; University of Liverpool; Liverpool UK

10. Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research; The Capital Region of Denmark, Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark

11. Department of Obstetrics and Gynaecology; Monash University; Clayton Australia

12. Aberdeen Centre for Women's Health Research, Institute of Applied Health Sciences, School of Medicine, Medial Sciences and Nutrition; University of Aberdeen; Aberdeen UK

13. Fetal Medicine Unit; St George's, University of London; London UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference160 articles.

1. Maternal nitric oxide supplementation increases adrenomedullin concentrations in growth retarded fetuses;Di Iorio;Gynecological Endocrinology,2002

2. STRIDER (NZAus): a randomised placebo-controlled trial of a new therapy (sildenafil) to help growth in severely growth restricted fetuses at very early gestations Http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12612000584831

3. STRIDER NZAus: a multicentre randomised controlled trial of sildenafil therapy in early-onset fetal growth restriction;Groom;BJOG: an international journal of obstetrics and gynaecology,2019

4. Sildenafil for severe, early-onset intrauterine growth restriction and neonatal cardiovascular function: a substudy of the strider NZAus randomised placebo-controlled trial;Harris;Journal of Paediatrics and Child Health,2019

5. Neonatal cardiovascular function after antenatal sildenafil for severe, early-onset intrauterine growth restriction: a substudy of the STRIDER NZAus randomized placebo-controlled trial;Harris;Journal of Pediatrics,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3